HRTX Q4 2017 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+686.0% YoY

Gross Profit

$9M86.7% margin

Operating Income

-$62M-615.6% margin

Net Income

-$62M-621.6% margin

EPS (Diluted)

$-0.97

QoQ Revenue Growth

+17.3%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$48M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$234M

Total Liabilities

$103M

Stockholders' Equity

$131M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$1M	+686.0%
Gross Profit	$9M	$1M	+600.6%
Operating Income	-$62M	-$47M	-32.2%
Net Income	-$62M	-$48M	-30.3%